List of works by Celeste Lebbe

Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

scientific article published on 07 August 2019

Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma

scientific article

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

scientific article

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

scientific article published on 06 August 2015

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

scientific article

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

scientific article

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

scientific article published on 30 September 2020

Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma

scientific article published on 17 March 2015

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

scientific article

Ipilimumab reshapes T cell memory subsets in melanoma patients with clinical response.

scientific article published on 18 February 2016

Management of immune-related adverse events resulting from immune checkpoint blockade

scientific article published on 09 January 2019

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

scientific article published on 19 July 2019

Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group

scientific article published on 29 September 2020

Relevance of serum biomarkers associated with melanoma during follow-up of anti-CTLA-4 immunotherapy.

scientific article published on 8 October 2016

STAT3 mediates Nilotinib response in KIT-altered Melanoma: a Phase II Multicenter Trial of the French Skin Cancer Network.

scientific article published on 23 August 2017

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

scientific article

Paulina is supported by:

About Paulina

Help